South Korea vs Mauritius: Previously treated cases tested for RR-/MDR-TB
South Korea
100.0%
in 2024
Mauritius
100.0%
in 2022
South Korea rank
1st
Mauritius rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- South Korea
- Mauritius
How they compare
South Korea currently reports 100.0% against 100.0% in Mauritius, a difference of 0.0%.
The two have swapped places 2 times across 11 shared years of data; in 2011 it was Mauritius ahead.
South Korea ranks 1st and Mauritius ranks 1st of 180 countries.
Mauritius has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | South Korea | Mauritius | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 55.5% | 95.0% | 39.5% | Mauritius |
| 2020s | 86.7% | 100.0% | 13.3% | Mauritius |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, South Korea or Mauritius?
- South Korea, at 100.0% against 100.0% in Mauritius as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between South Korea and Mauritius?
- 0.0%, with South Korea ahead.
- How many years of comparable data are there for South Korea and Mauritius?
- 11 years are reported by both, from 2011 to 2022.
- How do South Korea and Mauritius rank globally for previously treated cases tested for rr-/mdr-tb?
- South Korea ranks 1st and Mauritius ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.